- Home
- PRPH
as 07-26-2024 4:00pm EST
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 91.0M | IPO Year: | 1997 |
| Target Price: | $11.00 | AVG Volume (30 days): | 31.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.03 - $7.55 | Next Earning Date: | 08-08-2024 |
| Revenue: | $28,715,000 | Revenue Growth: | -69.59% |
| Revenue Growth (this year): | 8.14% | Revenue Growth (next year): | 193.82% |
Latest ProPhase Labs Inc. (DE) News
PRPH Breaking Stock News: Dive into PRPH Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
CNW Group
2 months ago
Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024
ACCESSWIRE
2 months ago
Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge
Business Insider
2 months ago
Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies
GlobeNewswire
2 months ago
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
Motley Fool
2 months ago
Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger
CNW Group
2 months ago
Unifor members vote to strike at Manitoba Hydro
AFP
2 months ago
Croatia beat Portugal in Euro 2024 warm-up friendly
Compare PRPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRPH ProPhase Labs Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.